Volume 92, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



In addition to being effective, fast-acting, and well tolerated, artemisinin-based combination therapies (ACTs) are able to kill certain transmission stages of the malaria parasite. However, the population-level impacts of ACTs on reducing malaria transmission have been difficult to assess. In this study on the history of malaria control in Vietnam, we assemble annual reporting on malaria case counts, coverage with insecticide-treated nets (ITN) and indoor residual spraying (IRS), and drug purchases by provincial malaria control programs from 1991 to 2010 in Vietnam's 20 southern provinces. We observe a significant negative association between artemisinin use and malaria incidence, with a 10% absolute increase in the purchase proportion of artemisinin-containing regimens being associated with a 29.1% (95% confidence interval: 14.8–41.0%) reduction in slide-confirmed malaria incidence, after accounting for changes in urbanization, ITN/IRS coverage, and two indicators of health system capacity. One budget-related indicator of health system capacity was found to have a smaller association with malaria incidence, and no other significant factors were found. Our findings suggest that including an artemisinin component in malaria drug regimens was strongly associated with reduced malaria incidence in southern Vietnam, whereas changes in urbanization and coverage with ITN or IRS were not.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

Loading full text...

Full text loading...



  1. World Health Organization, 2013. World Malaria Report. Available at: http://www.who.int/malaria/publications/world_malaria_report_2013/en. Accessed July 23, 2014.
  2. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI, , 2005. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434: 214217.[Crossref]
  3. Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD, , 2012. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379: 413431.[Crossref]
  4. Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N, , 2004. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363: 917.[Crossref]
  5. White NJ, , 1997. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo . Antimicrob Agents Chemother 41: 14131422.
  6. Bhattarai A, Ali AS, Kachur SP, Mårtensson A, Abbas AK, Khatib R, Al-Mafazy AW, Ramsan M, Rotllant G, Gerstenmaier JF, Molteni F, Abdulla S, Montgomery SM, Kaneko A, Björkman A, , 2007. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med 4: 17841790.[Crossref]
  7. World Health Organization, 2010. Guidelines for the Treatment of Malaria. Second edition. Available at: http://www.who.int/malaria/publications/atoz/9789241547925/en. Accessed July 23, 2014.
  8. White NJ, , 2008. The role of anti-malarial drugs in eliminating malaria. Malar J 7 (Suppl 1): S8.[Crossref]
  9. The Global Health Group and the Malaria Atlas Project, 2011. Atlas of Malaria-Eliminating Countries. Available at: http://www.malariaeliminationgroup.org/sites/default/files/atlas/global/Global-Atlas-2011.pdf. Accessed July 23, 2014.
  10. United Nations Children's Fund, 2009. Malaria and Children. Available at: http://www.unicef.org/health/files/WMD_optimized_reprint.pdf. Accessed July 23, 2014.
  11. O'Meara WP, Mangeni JN, Steketee R, Greenwood B, , 2010. Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis 10: 545555.[Crossref]
  12. Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E, Dlamini SS, Tsoka J, Bredenkamp B, Mthembu DJ, White NJ, Sharp BL, , 2005. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med 2: 11231134.[Crossref]
  13. Van Nam N, de Vries PJ, Van Toi L, Nagelkerke N, , 2005. Malaria control in Vietnam: the Binh Thuan experience. Trop Med Int Health 10: 357365.[Crossref]
  14. Okell LC, Drakeley CJ, Bousema T, Whitty CJ, Ghani AC, , 2008. Modeling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med 5: 16171628.[Crossref]
  15. Price RN, Nosten F, Luxemburger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ, , 1996. Effects of artemisinin derivatives on malaria transmissibility. Lancet 347: 16541658.[Crossref]
  16. Carrara VI, Sirilak S, Thonglairuam J, Rojanawatsirivet C, Proux S, Gilbos V, Gilbos V, Brockman A, Ashley EA, McGready R, Krudsood S, Leemingsawat S, Looareesuwan S, Singhasivanon P, White N, Nosten F, , 2006. Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative. PLoS Med 3: 856864.[Crossref]
  17. Schuftan C, , 2000. A Story to be Shared: The Successful Fight against Malaria in Vietnam. Available at: http://www.afronets.org/files/malaria.pdf. Accessed July 23, 2014.
  18. Ettling MB, , 2002. The Control of Malaria in Viet Nam from 1980 to 2000: What Went Right? Available at: http://zanran_storage.s3.amazonaws.com/www.wpro.who.int/ContentPages/20813052.pdf. Accessed July 23, 2014.
  19. Heston A, Summers R, Aten B, , 2012. Penn World Table Version 7.1. Available at: https://pwt.sas.upenn.edu/php_site/pwt71/pwt71_form.php. Accessed July 23, 2014.
  20. Liang KY, Zeger SL, , 1986. Longitudinal data analysis using generalized linear models. Biometrika 73: 1322.[Crossref]
  21. Huber PJ, , 1967. The behavior of maximum likelihood estimates under nonstandard conditions. Proc Fifth Berkeley Symp Math Stat Probab, 221233.
  22. Yan J, , 2002. geepack: yet another package for generalized estimating equations. R-News 2: 1214.
  23. Yan J, Fine JP, , 2004. Estimating equations for association structures. Stat Med 23: 859880.[Crossref]
  24. Højsgaard S, Halekoh U, Yan J, , 2006. The R package geepack for generalized estimating equations. J Stat Softw 15: 111.
  25. Tediosi F, Maire N, Smith T, Hutton G, Utzinger J, Ross A, Tanner M, , 2006. An approach to model the costs and effects of case management of Plasmodium falciparum malaria in sub-Saharan Africa. Am J Trop Med Hyg 75: 90103.
  26. Thanh NV, Toan TQ, Cowman AF, Casey GJ, Phuc BQ, Tien NT, Hung NM, Biggs BA, , 2010. Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998–2009. Malar J 9: 181.[Crossref]
  27. Huong NM, Hewitt S, Davis ME, Dao LD, Toan TQ, Kim TB, Hanh NT, Phuong VN, Nhan DH, Cong LD, , 2001. Resistance of Plasmodium falciparum to antimalarial drugs in a highly endemic area of southern Viet Nam: a study in vivo and in vitro . Trans R Soc Trop Med Hyg 95: 325329.[Crossref]
  28. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, ler Moo C, Al-Saai S, Dondorp AM, Lwin MK, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F, , 2012. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 379: 19601966.[Crossref]
  29. Hien TT, Thuy-Nhien NT, Phu NH, Boni MF, Thanh NV, Nha-Ca NT, Thai LH, Thai CQ, Toi PV, Thuan PD, Long LT, Dong LT, Merson L, Dolecek C, Stepniewska K, Ringwald P, White NJ, Farrar J, Wolbers M, , 2012. In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam. Malar J 11: 355.[Crossref]
  30. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Mao S, Sam B, Sopha C, Chuor CM, Nguon C, Sovannaroth S, Pukrittayakamee S, Jittamala P, Chotivanich K, Chutasmit K, Suchatsoonthorn C, Runcharoen R, Hien TT, Thuy-Nhien NT, Thanh NV, Phu NH, Htut Y, Han KT, Aye KH, Mokuolu O, Olaosebikan RR, Folaranmi OO, Mayxay M, Khanthavong M, Hongvanthong B, Newton PN, Onyamboko MA, Fanello CI, Tshefu AK, Mishra N, Valecha N, Phyo AP, Nosten F, Yi P, Tripura R, Borrmann S, Bashraheil M, Peshu J, Faiz MA, Ghose A, Hossain MA, Samad R, Rahman MR, Hasan MM, Islam A, Miotto O, Amato R, MacInnis B, Stalker J, Kwiatkowski DP, Bozdech Z, Jeeyapant A, Cheah PY, Sakulthaew T, Chalk J, Intharabut B, Silamut K, Lee SJ, Vihokhern B, Kunasol C, Imwong M, Tarning J, Taylor WJ, Yeung S, Woodrow CJ, Flegg JA, Das D, Smith J, Venkatesan M, Plowe CV, Stepniewska K, Guerin PJ, Dondorp AM, Day NP, White NJ, , 2014. The spread of artemisinin resistance in falciparum malaria. N Engl J Med 371: 411423.[Crossref]
  31. Dondorp A, Nosten F, Yi P, Debashish D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Simalut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Sinhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, , 2009. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361: 455467.[Crossref]
  32. Boni MF, Smith DL, Laxminarayan R, , 2008. Benefits of using multiple first-line therapies against malaria. Proc Natl Acad Sci USA 105: 1421614221.[Crossref]
  33. Hastings I, , 2011. How artemisinin-containing combination therapies slow the spread of antimalarial drug resistance. Trends Parasitol 27: 6772.[Crossref]
  34. Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, Brockman A, McGready R, ter Kuile F, Looareesuwan S, White NJ, , 2000. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356: 297302.[Crossref]

Data & Media loading...

Supplementary Data

Supplementary PDF

  • Received : 23 Jul 2014
  • Accepted : 26 Dec 2014

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error